rs2296601

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000043.6(FAS):​c.334+46C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.13 in 1,611,144 control chromosomes in the GnomAD database, including 17,569 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.17 ( 2617 hom., cov: 32)
Exomes 𝑓: 0.13 ( 14952 hom. )

Consequence

FAS
NM_000043.6 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.346

Publications

13 publications found
Variant links:
Genes affected
FAS (HGNC:11920): (Fas cell surface death receptor) The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor contains a death domain. It has been shown to play a central role in the physiological regulation of programmed cell death, and has been implicated in the pathogenesis of various malignancies and diseases of the immune system. The interaction of this receptor with its ligand allows the formation of a death-inducing signaling complex that includes Fas-associated death domain protein (FADD), caspase 8, and caspase 10. The autoproteolytic processing of the caspases in the complex triggers a downstream caspase cascade, and leads to apoptosis. This receptor has been also shown to activate NF-kappaB, MAPK3/ERK1, and MAPK8/JNK, and is found to be involved in transducing the proliferating signals in normal diploid fibroblast and T cells. Several alternatively spliced transcript variants have been described, some of which are candidates for nonsense-mediated mRNA decay (NMD). The isoforms lacking the transmembrane domain may negatively regulate the apoptosis mediated by the full length isoform. [provided by RefSeq, Mar 2011]
FAS Gene-Disease associations (from GenCC):
  • autoimmune lymphoproliferative syndrome
    Inheritance: AD, AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • autoimmune lymphoproliferative syndrome type 1
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 10-89007883-C-T is Benign according to our data. Variant chr10-89007883-C-T is described in ClinVar as Benign. ClinVar VariationId is 1235502.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.427 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FASNM_000043.6 linkc.334+46C>T intron_variant Intron 3 of 8 ENST00000652046.1 NP_000034.1 P25445-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FASENST00000652046.1 linkc.334+46C>T intron_variant Intron 3 of 8 NM_000043.6 ENSP00000498466.1 P25445-1

Frequencies

GnomAD3 genomes
AF:
0.168
AC:
25448
AN:
151918
Hom.:
2603
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.230
Gnomad AMI
AF:
0.0669
Gnomad AMR
AF:
0.194
Gnomad ASJ
AF:
0.105
Gnomad EAS
AF:
0.442
Gnomad SAS
AF:
0.200
Gnomad FIN
AF:
0.169
Gnomad MID
AF:
0.158
Gnomad NFE
AF:
0.105
Gnomad OTH
AF:
0.164
GnomAD2 exomes
AF:
0.165
AC:
41134
AN:
248930
AF XY:
0.161
show subpopulations
Gnomad AFR exome
AF:
0.226
Gnomad AMR exome
AF:
0.191
Gnomad ASJ exome
AF:
0.0988
Gnomad EAS exome
AF:
0.450
Gnomad FIN exome
AF:
0.170
Gnomad NFE exome
AF:
0.104
Gnomad OTH exome
AF:
0.148
GnomAD4 exome
AF:
0.126
AC:
184478
AN:
1459108
Hom.:
14952
Cov.:
34
AF XY:
0.127
AC XY:
92369
AN XY:
725930
show subpopulations
African (AFR)
AF:
0.225
AC:
7502
AN:
33416
American (AMR)
AF:
0.191
AC:
8548
AN:
44666
Ashkenazi Jewish (ASJ)
AF:
0.103
AC:
2691
AN:
26114
East Asian (EAS)
AF:
0.448
AC:
17778
AN:
39678
South Asian (SAS)
AF:
0.179
AC:
15465
AN:
86188
European-Finnish (FIN)
AF:
0.160
AC:
8277
AN:
51800
Middle Eastern (MID)
AF:
0.117
AC:
671
AN:
5756
European-Non Finnish (NFE)
AF:
0.103
AC:
114710
AN:
1111180
Other (OTH)
AF:
0.147
AC:
8836
AN:
60310
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
8921
17841
26762
35682
44603
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4568
9136
13704
18272
22840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.168
AC:
25498
AN:
152036
Hom.:
2617
Cov.:
32
AF XY:
0.172
AC XY:
12802
AN XY:
74308
show subpopulations
African (AFR)
AF:
0.231
AC:
9557
AN:
41446
American (AMR)
AF:
0.194
AC:
2967
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.105
AC:
363
AN:
3464
East Asian (EAS)
AF:
0.442
AC:
2285
AN:
5166
South Asian (SAS)
AF:
0.200
AC:
963
AN:
4818
European-Finnish (FIN)
AF:
0.169
AC:
1785
AN:
10560
Middle Eastern (MID)
AF:
0.156
AC:
46
AN:
294
European-Non Finnish (NFE)
AF:
0.105
AC:
7123
AN:
67986
Other (OTH)
AF:
0.165
AC:
348
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1048
2096
3143
4191
5239
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
262
524
786
1048
1310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.130
Hom.:
281
Bravo
AF:
0.168
Asia WGS
AF:
0.346
AC:
1204
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Nov 12, 2023
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 20% of patients studied by a panel of primary immunodeficiencies. Number of patients: 19. Only high quality variants are reported. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
6.5
DANN
Benign
0.63
PhyloP100
0.35
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2296601; hg19: chr10-90767640; COSMIC: COSV58238899; COSMIC: COSV58238899; API